Quantcast

Latest Zoledronic acid Stories

2011-12-08 12:51:26

Results from a German study demonstrated no improvement in disease-free survival among patients with breast cancer who were treated with dose-dense chemotherapy and the bisphosphonate ibandronate. Volker Möbus, Ph.D., head of the department of obstetrics and gynecology at Klinikum Frankfurt Höchst GmbH in Frankfurt, presented the results from the German Adjuvant Intergroup Node Positive (GAIN) Study, at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium, held...

2011-12-07 21:36:01

The addition of zoledronic acid to adjuvant endocrine therapy increased bone mineral density and reduced the risk for disease recurrence among postmenopausal women with early hormone receptor-positive breast cancer, according to new data from the ZO-FAST trial. Richard de Boer, M.D., of the Royal Melbourne Hospital in Victoria, Australia, presented long-term data from the Zometa-Femara Adjuvant Synergy Trial (ZO-FAST) trial at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium, held...

2011-12-07 21:34:36

Researchers have proven the continuing effectiveness of treating patients with estrogen receptor-positive premenopausal breast cancer with adjuvant zoledronic acid in addition to adjuvant endocrine treatment including ovarian function suppression. Data from the Austrian Breast & Colorectal Cancer Study Group (ABCSG-12), reported at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 6-10, 2011, confirmed and extended data reported at 48 months and 62 months of follow-up....

2011-10-13 05:31:23

(Ivanhoe Newswire) — An osteoporosis drug protects against the bone damaging effects of certain breast cancer medications. According to this study, some breast cancer patients could take zoledronic acid in addition to their anti-cancer medications to maintain bone health. Drugs called aromatase inhibitors stop the production of estrogen in postmenopausal women and therefore make less estrogen available to stimulate the growth of certain breast cancer cells. Many postmenopausal women...

2011-10-10 09:17:18

A new study has found that an osteoporosis drug protects against the bone damaging side effects of certain breast cancer medications. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study indicates that some breast cancer patients could take zoledronic acid in addition to their anti-cancer medications to maintain bone health. Drugs called aromatase inhibitors stop the production of estrogen in postmenopausal women and therefore make less...

2011-09-30 05:40:19

(Ivanhoe Newswire) -- A new study suggests adding zoledronic acid to a drug regimen for patients with early stage breast cancer does not improve outcome. Zoledronic acid is a bisphosphonate that is used to treat osteoporosis and prevent skeletal fractures in patients with some types of cancer. In previous studies, bisphosphonates were shown to prevent or delay cancer metastasis and even reduce rates of recurrence and death. Researchers randomly assigned 3,360 patients to receive...

2011-09-26 15:17:32

A drug used to protect bone may extend survival in older breast cancer patients, according to researchers at the Universities of Sheffield and Leeds. The AZURE trial, led by Professor Robert Coleman from the University of Sheffield, has revealed that the bisphosphonate drug zoledronic acid boosts disease-free survival in postmenopausal breast cancer patients but may have an adverse effect on younger women. The full results of the trial were presented today (25 September 2011) at the...

2011-09-26 12:19:48

A trial investigating the use of zoledronic acid to aid chemotherapy for breast cancer has found a significant benefit for post-menopausal women, according to results presented at the 2011 European Multidisciplinary Cancer Congress today (Sunday). Researchers think it could be the key for a greater understanding of the mechanisms of breast cancer recurrence as well as offering new options for patient care. Zoledronic acid is one of the bisphosphonates, a group of drugs mainly used to treat...


Word of the Day
endocarp
  • The hard inner (usually woody) layer of the pericarp of some fruits (as peaches or plums or cherries or olives) that contains the seed.
This word comes from the Greek 'endon,' in, within, plus the Greek 'karpos', fruit.
Related